EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives

Christian S Carnero Canales iD, Ana Clara Lunardi Yagi iD, Túlio Custódio Reis iD, Jessica Ingrid Cazorla iD, Jade Rojas Villar, Marcia A Graminha, Roxana Yesenia Pastrana Alta, Fernando Rogério Pavan iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70493 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemMedChem, 2026. Verfasst von Christian S Carnero Canales und 7 weiteren Autor:innen. Beteiligte Einrichtung: BIOMET Laboratorio de Química Bioinorgánica en Medicina, Medioambiente y Tecnología, Facultad de Ciencias de la Universidad Nacional de Ingeniería, L…. Hauptthemen laut MEDLINE: Leishmaniasis, Malaria, Peptides, Nanoparticles. Die Arbeit nennt 256 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Program for Scientific Research and Advanced Studies, Interinstitutional Alliances for Doctoral Programs, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria and leishmaniasis continue to impose a substantial health burden, while current therapeutic and diagnostic strategies remain limited by toxicity, prolonged regimens, drug resistance, and restricted field applicability. This review examines recent advances in peptide‐enabled nanoplatforms for both diseases, with emphasis on intracellular targeting, drug delivery, and diagnostic innovation. Antimicrobial peptides, cell‐penetrating peptides, peptoids, mimotopes, and peptide‐functionalized nanocarriers have been explored to improve parasite targeting, intracellular delivery, pharmacokinetics, and antiparasitic efficacy. In parallel, peptide‐ and aptamer‐based nanosensors have expanded the detection of clinically relevant biomarkers, including HRP2, pLDH, GP63, KMP‐11, and kDNA, highlighting their potential for sensitive and modular diagnostics. Despite these advances, translation remains constrained by limited in vivo validation, insufficient pharmacokinetic standardization, incomplete toxicity profiling, poor batch reproducibility, protein corona‐associated variability, and scarce validation under field‐relevant conditions. Peptide‐enabled nanoplatforms are therefore most likely to succeed when aligned with stage‐specific parasite biology, realistic host cell‐targeting requirements, and scalable implementation pathways in endemic settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeishmaniasisMalariaPeptidesNanoparticlesHumansAnimalsLeishmaniaCell-Penetrating PeptidesDrug Delivery Systems

Stichwörter der Autor:innen

antimicrobial peptidescell‐penetrating peptidesleishmaniasismalariananocarriersnanoplatforms

Substanzen

PeptidesCell-Penetrating Peptides

Autor:innen und Institutionen

  • BIOMET Laboratorio de Química Bioinorgánica en Medicina, Medioambiente y Tecnología, Facultad de Ciencias de la Universidad Nacional de Ingeniería, Lima, Peru.
  • School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
  • General humanidades, Universidad Continental (UC), Arequipa, Perú.
  • School of Pharmacy, Biochemistry and Biotechnology, Universidad Católica Santa María (UCSM), Arequipa, Perú.

ORCID-Profile: Christian S Carnero Canales, Ana Clara Lunardi Yagi, Túlio Custódio Reis, Jessica Ingrid Cazorla, Fernando Rogério Pavan

Förderung

  • National Program for Scientific Research and Advanced Studies
  • Interinstitutional Alliances for Doctoral Programs
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Carnero Canales, C. S., Lunardi Yagi, A. C., Reis, T. C., Cazorla, J. I., Rojas Villar, J., Graminha, M. A., Pastrana Alta, R. Y., & Pavan, F. R. (2026). Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives. ChemMedChem. https://doi.org/10.1002/cmdc.70493

Vancouver

Carnero Canales CS, Lunardi Yagi AC, Reis TC, Cazorla JI, Rojas Villar J, Graminha MA, et al. Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives. ChemMedChem. 2026. doi:10.1002/cmdc.70493

BibTeX
@article{CarneroCanales2026,
  author = {Carnero Canales, Christian S and Lunardi Yagi, Ana Clara and Reis, Túlio Custódio and Cazorla, Jessica Ingrid and Rojas Villar, Jade and Graminha, Marcia A and Pastrana Alta, Roxana Yesenia and Pavan, Fernando Rogério},
  title = {Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70493}
}
Kostenlos starten →